CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
通过多组学方法鉴定的CCL14,可作为淋巴管肌瘤病疾病严重程度和进展的新型指标。
期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-025-04193-2
Bai, Wenxue; Hua, Lijuan; Wang, Xuezhao; Guo, Mengyao; Chen, Lirong; Liu, Bingyi; Wang, Yi; Zhou, Ying; Wang, Qi; Zhang, Ni; Xie, Min